期刊文献+

超滤在失代偿性心力衰竭患者中的应用 被引量:2

Application of Ultrafiltration in Patients with Decompensated Heart Failure
下载PDF
导出
摘要 目的评价超滤治疗失代偿性心力衰竭患者的效果。方法选择2016年11月-2017年11月郑州大学附属郑州中心医院41例因失代偿性心力衰竭行超滤治疗的患者,通过分析超滤前后患者的呼吸困难评分、氧分压(PaO2)、心排量(CO)、乳酸水平、左室射血分数、BNP等指标,评价超滤治疗的效果。结果超滤治疗后患者的呼吸困难评分、氧分压(PaO2)、心排量(CO)、乳酸水平、左室射血分数、BNP、肝肾功能等指标均较前改善,差异具有统计学意义(P<0.05)。结论超滤治疗可改善失代偿性心力衰竭患者的呼吸困难症状及心衰指标。 Objective To evaluate the effect of ultrafiltration on decompensated heart failure.Methods 41 patients with decompensated heart failure admitted to Zhengzhou Central Hospital Affiliated to Zhengzhou University from November 2016 to November 2017 were selected as research subjects.The efficacy of ultrafiltration therapy was evaluated by analyzing dyspnea score,partial oxygen pressure(PaO2),cardiac discharge rate(CO),lactic acid level,left ventricular ejection fraction,BNP and hepatorenal function before and after ultrafiltration.Results After ultrafiltration treatment,dyspnea score,partial oxygen pressure(PaO2),cardiac displacement(CO),lactic acid level,left ventricular ejection fraction,BNP,liver and kidney function were all improved,and the differences were statistically significant(P<0.05).Conclusion Ultrafiltration therapy can ameliorate the symptom of dyspnea and indexes of heart failure on patients with decompensated heart failure.
作者 马冬璞 杨艳鹏 MA Dongpu;YANG Yanpeng(Zhengzhou Central Hospital Affiliated to Zhengzhou University,Zhengzhou Henan 450006,China)
出处 《临床研究》 2020年第5期18-20,共3页 Clinical Research
关键词 心力衰竭 超滤 利尿剂 heart failure ultrafiltration therapy diuretics
  • 相关文献

参考文献5

二级参考文献62

  • 1张强.治疗急性失代偿性心力衰竭的新药——冻干重组人脑利钠肽[J].中国药房,2007,18(16):1264-1265. 被引量:10
  • 2袁方,潘欣,倪幼方,王涛,陆静,蒋锦琪,方唯一.重组人脑利钠肽改善急性失代偿性心力衰竭患者早期心功能[J].上海交通大学学报(医学版),2007,27(7):853-855. 被引量:14
  • 3Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A.
  • 4Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162.
  • 5Packer M, Coats AJS, Fowler MB, et al. For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658.
  • 6Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J, 2001, 22: 1527-1561.
  • 7Hunt HA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2001, 104:2996-3007.
  • 8无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3680
  • 9Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics- 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [J]. Circulation, 2009, 119 (3) : 480-486.
  • 10Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the UnitedStates: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [ J ]. Am Heart J, 2005,149 ( 2 ) : 209-216.

共引文献5033

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部